ArticleESMO gastrointestinal oncology2026
Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancer.
V De Falco et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.